APG Asset Management US’s Teva Pharmaceuticals TEVA Stock Holding History

APG Asset Management US’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-23,412	Closed	-$470K	–	168
2025 Q3	$470K	Hold	23,412	–	–	﹤0.01%	163
2025 Q2	$390K	Hold	23,412	–	–	﹤0.01%	170
2025 Q1	$358K	Hold	23,412	–	–	﹤0.01%	181
2024 Q4	$516K	Sell	23,412 -2,612	-10%	-$47.5K	﹤0.01%	162
2024 Q3	$460K	Sell	26,024 -293,715	-92%	-$5.14M	﹤0.01%	140
2024 Q2	$5.22M	Buy	319,739 +7,692	+2%	+$118K	0.03%	139
2024 Q1	$4.34M	Buy	312,047 +98,370	+46%	+$1.24M	0.03%	157
2023 Q4	$2.23M	Buy	+213,677	New	+$1.99M	0.01%	173

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

APG Asset Management US's TEVA Position: Q4 2025 in Review

APG Asset Management US sold out of Teva Pharmaceuticals (TEVA) in Q4 2025, closing a stake of 23,412 shares — an estimated $470K sold.

APG Asset Management US first reported a position in TEVA in Q4 2023 and held it in 8 quarters. The position peaked at $5.22M in Q2 2024. 631 funds tracked by Wall St. Rank hold TEVA as of Q4 2025.

APG Asset Management US reported no remaining Teva Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
APG Asset Management US sold 23,412 Teva Pharmaceuticals shares in Q4 2025, an estimated $470K.
APG Asset Management US first reported a position in Teva Pharmaceuticals in Q4 2023 and held it in 8 quarters.
APG Asset Management US's Teva Pharmaceuticals position peaked at $5.22M in Q2 2024.
631 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2025.

Based on APG Asset Management US's 13F filing for Q4 2025, filed 12 Feb 2026.